Here is the well known example of Prana being on the other side of a patent dispute where Greek pharma PN Gerolymatos held the patent for clioquinol for stomach bugs and Prana patented it for neurodegeneration for its metal chelating abilities. As I remember they called in the pharma for consultation and the pharma patented it as well. Maybe even first. Then Prana was in a dispute to register their IP. I guess that is where GK learned it is best to keep secrets till the patents are done.
GK was there then, so is no stranger to a dispute of this nature. Dianne Angus was also there when it was settled in 2004.
https://www.labonline.com.au/content/life-scientist/news/prana-settles-clioquinol-dispute-16898714
It has been known for some time that 8-OHQs can be effective against antibiotic resistant bacteria. As I posted above 2014:
The activity of 8HQ mostly was observed for resistant pathogens, gram- positive bacteria e.g. Staphylococcus aureus, Enterococcus faecalis and diploid fungus, Candida albicans.
https://scialert.net/fulltextmobile/?doi=ijp.2013.170.175
Here is the well known example of Prana being on the other side...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $200 | 66.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 53 | 75238609 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 4967441 | 3 |
View Market Depth
| Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |